Dotor De Las Herrerias, Javier,Lopez Vazquez, Ana Belen,Lasarte Sagastibelza, Juan Jose,Prieto Valtuena, Jesus,Borras Cuesta, Francisco
申请号：
AU2010212466
公开号：
AU2010212466B2
申请日:
2010.08.20
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
#$%^&*AU2010212466B220120719.pdf#####ABSTRACT The described peptides possess the capacity to bind to Transforming Growth Factor 5 TGF-pl (TGF-p1), and are potential inhibitors of the biological activity of TGF-p1 through direct binding to this cytokine. These peptides can be used in the treatment of diseases or pathological alterations based on excessive or deregulated TGF-P 1 expression.P15aa DNA pVI pV1l pill Figure 1 5'-GCC GAC GGG GCT (NNK)15 GGG GCC GCT GGG GCC-3' NH2-X1 -GAAGA-Prot pill P15aa Figure 2
